0 Comments
0 Shares
358 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Companion Diagnostics Market Advances Precision MedicineAccording to a report by Intel Market Research, the global Companion Diagnostics Market was valued at USD 7.1 billion in 2025 and is projected to grow from USD 7.8 billion in 2026 to USD 14.3 billion by 2034, exhibiting a CAGR of 8.1% during the forecast period. The market is expanding rapidly as precision medicine becomes an integral component of modern healthcare, particularly in oncology....0 Comments 0 Shares 217 Views 0 Reviews
-
Companion Diagnostics Market Gains Momentum with Rising Adoption of Targeted TherapiesThe global companion diagnostics market is poised for significant expansion, driven by rapid advancements in genomic and molecular testing technologies, increasing adoption of personalized medicine, growing demand for targeted oncology therapies, and supportive regulatory initiatives worldwide. The global companion diagnostics market is entering a new phase of growth...0 Comments 0 Shares 280 Views 0 Reviews
-
Pet Biochemistry Analyzer Market - Veterinary Diagnostics Expanding Companion Animal Health MonitoringMarket Overview The pet biochemistry analyzer market is expanding as veterinary diagnostics deepen companion animal health monitoring capabilities. The Pet Biochemistry Analyzer Market is projected to grow through 2030, driven by rising pet ownership rates, growing pet owner willingness to invest in preventive care, expanding veterinary clinic diagnostic capacity, and increasing demand for...0 Comments 0 Shares 248 Views 0 Reviews
-
Tissue Diagnostics Market - Companion Diagnostics Growth Linking Biomarker to Targeted TherapyMarket Overview The tissue diagnostics market is growing as companion diagnostics links biomarker to targeted therapy across oncology drug development and patient selection. The Tissue Diagnostics Market is projected to grow through 2035, driven by PD-L1 testing expansion, HER2 testing standardization, and emerging biomarker validation supporting improved treatment matching and regulatory...0 Comments 0 Shares 313 Views 0 Reviews